Home/Filings/4/0001683168-17-000256
4//SEC Filing

AETHLON MEDICAL INC 4

Accession 0001683168-17-000256

$AEMDCIK 0000882291operating

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 2:54 PM ET

Size

7.8 KB

Accession

0001683168-17-000256

Insider Transaction Report

Form 4
Period: 2017-02-07
Joyce James A
DirectorChair., Pres., CEO, CFO, Sec.10% Owner
Transactions
  • Disposition to Issuer

    Restricted Stock Units

    2017-02-0798,107535,893 total
    Common Stock (98,107 underlying)
  • Exercise/Conversion

    Common Stock

    2017-02-07$4.28/sh+98,107$419,89898,107 total
Footnotes (3)
  • [F1]In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units: options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above.
  • [F2]Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016.
  • [F3]158,500 of the restricted stock units vested on the grant date, and 39,625 restricted stock units will vest each quarter beginning 1/1/17Represents conversion of restricted stock units with common stock issued on February 7, 2017.

Issuer

AETHLON MEDICAL INC

CIK 0000882291

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0000882291

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 2:54 PM ET
Size
7.8 KB